Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeWages, Salaries and Other
Others
Ratios

Armata Pharmaceuticals (ARMP) Interest Expenses (2016 - 2018)

Armata Pharmaceuticals (ARMP) has disclosed Interest Expenses for 6 consecutive years, with $324000.0 as the latest value for Q4 2018.

  • Quarterly Interest Expenses changed N/A to $324000.0 in Q4 2018 from the year-ago period, while the trailing twelve-month figure was $912000.0 through Dec 2018, up 91100.0% year-over-year, with the annual reading at $16.6 million for FY2025, 54.44% up from the prior year.
  • Interest Expenses hit $324000.0 in Q4 2018 for Armata Pharmaceuticals, up from $307000.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $8.8 million in Q1 2014 to a low of -$129000.0 in Q3 2015.
  • Historically, Interest Expenses has averaged $1.2 million across 5 years, with a median of $307000.0 in 2018.
  • Biggest five-year swings in Interest Expenses: surged 9038.54% in 2014 and later plummeted 95.09% in 2015.
  • Year by year, Interest Expenses stood at $8.8 million in 2014, then crashed by 101.47% to -$129000.0 in 2015, then soared by 353.49% to $327000.0 in 2016, then plummeted by 99.69% to $1000.0 in 2017, then surged by 32300.0% to $324000.0 in 2018.
  • Business Quant data shows Interest Expenses for ARMP at $324000.0 in Q4 2018, $307000.0 in Q3 2018, and $281000.0 in Q2 2018.